Yalcin, S., Dane, F., Oksuzoglu, B., Ozdemir, N. Y., Isikdogan, A., Ozkan, M., . . . Kilickap, S. (2020). Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study. BMC Cancer.
Citación estilo ChicagoYalcin, Suayib, et al. "Quality of Life Study of Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma Treated With Gemcitabine+nab-paclitaxel Versus Gemcitabine Alone: AX-PANC-SY001, a Randomized Phase-2 Study." BMC Cancer 2020.
Cita MLAYalcin, Suayib, et al. "Quality of Life Study of Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma Treated With Gemcitabine+nab-paclitaxel Versus Gemcitabine Alone: AX-PANC-SY001, a Randomized Phase-2 Study." BMC Cancer 2020.